Patient info

L04AX05 pirfenidone

ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases

This site has the patient leaflet or the SPC of 14 medicines in this group.

Active substance: Pirfenidone – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L04 Immunosuppressants 545 medicines
      1. L04A Immunosuppressants 543 medicines
        1. L04AX Other immunosuppressants 206 medicines
          1. L04AX05 pirfenidone 14 medicines

Medicines

MedicineLegal category
Esbriet 267 mg film-coated tablets SPC no longer supplied –
Esbriet 267 mg hard capsules SPC no longer supplied –
Esbriet 534 mg film-coated tablets SPC no longer supplied –
Esbriet 801 mg film-coated tablets SPC no longer supplied –
Pirfenidone 267 mg capsules hard SPC not available –
Pirfenidone 267 mg film-coated tablets SPC no longer supplied –
Pirfenidone 267 mg tablets SPC Prescription only (POM)
Pirfenidone 276 mg film-coated tablets SPC Prescription only (POM)
Pirfenidone 534 mg film-coated tablets SPC –
Pirfenidone 801 mg film-coated tablets SPC Prescription only (POM)
Pirfenidone 801 mg tablets SPC Prescription only (POM)
Pirfenidone Lupin 267 mg film-coated tablets SPC no longer supplied –
Pirfenidone Lupin 801 mg film-coated tablets SPC no longer supplied –
Pirfenidone, 534 mg tablets SPC –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L04AX05

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.